Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A mathematical approach for optimizing dendritic cell-based immunotherapy.

Gennady Bocharov1, Neville J Ford, Burkhard Ludewig

  • 1Institute of Numerical Mathematics, Russian Academy of Sciences, Moscow, Russia.

Methods in Molecular Medicine
|December 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PMGen: from peptide-MHC structure prediction to peptide generation.

Bioinformatics (Oxford, England)·2026
Same author

IL-33-induced ILC2 effector cytokine responses promote the expansion of red pulp macrophages.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Homeostatic mature dendritic cells instruct fibroblast specialization via Notch2 signaling to establish T cell niches.

Immunity·2026
Same author

Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity.

Science advances·2026
Same author

Dynamics and Sensitivity of the Lifecycle of Hepatitis B Virus.

Pathogens (Basel, Switzerland)·2026
Same author

Multiscale physiologically-based model of age-dependent CD4+ T-lymphocyte homeostasis.

Frontiers in immunology·2026
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Mathematical modeling aids dendritic cell (DC)-based immunotherapy by analyzing complex dynamics and improving treatment strategies. This study presents a computational method for data-driven models, focusing on parameter estimation and sensitivity analysis for enhanced cancer immunotherapy.

Area of Science:

  • Immunology and computational biology
  • Cancer immunotherapy research
  • Mathematical modeling in medicine

Background:

  • Adoptive dendritic cell (DC)-based immunotherapy shows promise for overcoming tolerance to tumor antigens and maintaining antitumor immunity.
  • Clinical translation of DC-based immunotherapy faces challenges due to complexities in the clinical setting.
  • Mathematical modeling offers tools for analyzing complex immunological systems and optimizing therapeutic strategies.

Purpose of the Study:

  • To present a computational methodology for developing data- and hypothesis-driven mathematical models for DC-based immunotherapy.
  • To focus on numerical parameter estimation and sensitivity analysis within these models.
  • To facilitate the design and improvement of DC-based therapeutic approaches.

Main Methods:

Related Experiment Videos

  • Development of a workable computational methodology for mathematical modeling.
  • Application of data-driven and hypothesis-driven approaches.
  • Implementation of numerical parameter estimation and sensitivity analysis techniques.

Main Results:

  • A computational methodology for creating meaningful mathematical models for DC-based immunotherapy was established.
  • The methodology incorporates parameter estimation and sensitivity analysis for model refinement.
  • This approach provides a framework for analyzing and optimizing immunotherapy strategies.

Conclusions:

  • Mathematical modeling is crucial for advancing DC-based immunotherapy by addressing clinical complexities.
  • The presented methodology offers a practical tool for developing and refining predictive models.
  • This work supports the improved design and application of adoptive cell therapies in cancer treatment.